青啤(00168.HK)AH股漲10%及9%半年多賺25%獲大行升價
青啤(00168.HK)(600600.SH)半年多賺25%,大和及瑞信績後升青啤H股目標價分別至53元及65元,分別反映公司均價改善毛利擴張及次季業績勝預期。青啤H股承過去兩天升勢,今早高見52.4元,創近三個月高,現造52.3元,續升9%,成交增至507萬股;其A股扭轉昨天整固勢,漲10%至停板報50.66元人民幣,創逾一個月高,成交急增至1,820萬股,創逾四個月高。
青啤公布,按中國會計準則,今年上半年純利按年增逾25%至16.31億元人民幣(下同),每股盈利1.207元,維持不派中期息。期內,總營收按年升逾9%至165.51億元。思達克財經新聞
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.